Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Controversies regarding long-acting β2-agonists.

Current opinion in allergy and clinical immunology - 1 Aug 2011

Khianey Reena, Oppenheimer John

Abstract excerpt

PURPOSE OF REVIEW: This review examines the literature regarding the efficacy and safety of long-acting β2-agonists as add-on therapy to inhaled corticosteroids. RECENT FINDINGS: The Global Initiative for Asthma (GINA) 2009 guidelines and the National Heart, Lung, and Blood Institute (NHLBI) 2007 asthma guidelines recommend adding long-acting β2-agonists to patients inadequately controlled on inhaled...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal Cortex Hormones
Share to Adrenergic beta-2 Receptor Agonists
Share to Albuterol

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Anti-Asthmatic Agents

Share to Cross-Over Studies

Share to Delayed-Action Preparations

Share to Ethanolamines

Share to Multicenter Studies as Topic

Source

Identifiers

PMID: 21659855
DOI: 10.1097/ACI.0b013e328348a82e

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Controversies regarding long-acting β2-agonists.PMID 21659855Read ↗

Safety of long-acting beta-agonists in asthma: a review.Semantic proximity Read ↗

β2 Agonists.Semantic proximity Read ↗

Benefit-risk assessment of long-acting beta2-agonists in asthma.Semantic proximity Read ↗

Safety and efficacy of beta agonists.Semantic proximity Read ↗

Pharmacogenetics of β2 adrenergic receptor gene polymorphisms, long-acting β-agonists and asthmaSemantic proximity Read ↗

Molecular Mechanisms of Combination Therapy With Inhaled Corticosteroids and Long-Acting β-AgonistsSemantic proximity Read ↗

Pharmacogenetics of β2-AgonistsSemantic proximity Read ↗

A comparison of the molecular pharmacological properties of current short, long and ultra-long-acting β2-agonists used for asthma and COPD.Semantic proximity Read ↗

Pharmacogenetics of beta2 adrenergic receptor agonists in asthma managementSemantic proximity Read ↗

Pharmacogenomics of long-acting β2-agonists.Semantic proximity Read ↗

Pharmacogenomics of beta2-agonist: key focus on signaling pathways.Semantic proximity Read ↗

Adverse effects of beta-agonists.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.